In the International Journal of Extreme Manufacturing, researchers have developed a new bioprinting strategy that allows ...
"Hepta is extending the power of liquid biopsy beyond oncology to reveal organ-level biology in chronic disease," said Hamed Amini, Ph.D., Co-founder and CEO of Hepta. "Our team, which developed next ...
For the millions of people living with end‑stage kidney disease, hemodialysis is more than a medical procedure, it is a thrice‑weekly lifeline that keeps the body's chemistry in balance. Yet even with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results